Home » Lexicon Shares Soar on Successful Drug Trial
Lexicon Shares Soar on Successful Drug Trial
Shares in Lexicon Pharmaceuticals Inc. soared after the biopharmaceuticals company announced it was moving forward with the second phase of clinical trials of a drug aimed at treating patients with type 2 diabetes.
Houston Business Journal
Houston Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May